Form 4: NHC CFO Exercises Options, Adjusts Holdings
Insider Transaction Report
National Healthcare Corp's SVP and CFO, Brian F. Kidd, exercised stock options and subsequently disposed of shares to cover exercise costs and tax obligations.
Summary
- Brian F. Kidd, SVP and CFO of National Healthcare Corp (NHC), exercised options to acquire 4,000 shares of common stock at $94.1 per share on November 11, 2025.
- Concurrently, Kidd disposed of 3,224 shares of common stock at $132.2 per share to satisfy the exercise price and withholding tax obligations.
- Following these transactions, Kidd directly beneficially owns 24,490 shares of NHC common stock.
- The exercised options were granted on March 5, 2024, under the 2020 Omnibus Equity Incentive Plan.
- Kidd continues to hold 8,000 options exercisable at $53.94 (expiring March 8, 2028), 8,000 options exercisable at $94.1 (expiring March 5, 2029), and 13,500 options exercisable at $90.62 (expiring February 24, 2030).
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as an insider exercised options, indicating confidence. However, the immediate sale of a portion of shares for tax purposes is a neutral, routine event.
Positives
- An insider, the SVP and CFO, exercised stock options, indicating confidence in the company's long-term value.
- The options were exercised at $94.1, while the shares disposed of for tax purposes were valued at $132.2, suggesting a significant in-the-money position for the exercised options.
Negatives
- A portion of the acquired shares (3,224 out of 4,000) was immediately disposed of, reducing the net increase in direct beneficial ownership. This is a common practice for tax and exercise cost coverage, but it still represents a reduction in direct holdings.
Future Outlook
NA
Industry Context
This Form 4 filing details a routine insider transaction for National Healthcare Corp's CFO and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Reference | The exercised stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan, indicating the company's established framework for executive compensation. | 2024-03-05 | Reinforces the company's existing executive compensation structure and adherence to its equity incentive plan. |
Stakeholder Impact
- Shareholders: The transaction slightly increases the public float (due to the net 776 shares added to the market from the exercise and sale, assuming the options were new shares) and provides transparency into executive compensation and insider holdings. The insider's continued holding of a significant number of shares and options may be viewed positively.
- Management: The transaction reflects the realization of value from previously granted equity compensation for the SVP and CFO.
Key Dates
| Date | Description |
|---|---|
| 2024-03-05 | Grant date of the 4,000 stock options exercised. |
| 2024-03-08 | Date exercisable for 8,000 options with an exercise price of $53.94. |
| 2025-03-05 | Date exercisable for the 4,000 options exercised and the remaining 8,000 options with an exercise price of $94.1. |
| 2025-11-11 | Transaction date for the exercise of stock options and disposition of shares. |
| 2025-11-13 | Signature date of the reporting person on the Form 4. |
| 2026-02-24 | Date exercisable for 13,500 options with an exercise price of $90.62. |
| 2028-03-08 | Expiration date for 8,000 options with an exercise price of $53.94. |
| 2029-03-05 | Expiration date for 8,000 options with an exercise price of $94.1. |
| 2030-02-24 | Expiration date for 13,500 options with an exercise price of $90.62. |
Recommendation
holdThis Form 4 filing details a routine insider transaction involving the exercise of stock options and a subsequent sale of shares to cover taxes and exercise costs. Such transactions are common for executives and do not typically signal a significant change in company fundamentals or future prospects. While the exercise indicates some insider confidence, the concurrent sale for tax purposes is a neutral event. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
National Healthcare Corp, NHC, Brian F. Kidd, SVP CFO, Insider Trading, Form 4, Stock Options, Equity Incentive Plan, Beneficial Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.